drugset / Trial / NCT04455126
Preservative-free Tafluprost Eye Drops in Newly Diagnosed Patients With Glaucoma
NaSingle-groupOpen-labelTreatment
Summary
Glaucoma encompasses a collective group of optic neuropathies characterized by progressive degeneration of retinal ganglion cells and their axons, resulting in cupping, a distinctive appearance of the optic disc, and a pattern of visual loss
Timeline
- Start
- 2018-04-01
- Primary completion
- 2018-12-30
- Completion
- 2020-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tafluprost | Other / unclassified | — | Other |